Human acyl-CoA: Cholesterol acyltransferase (hACAT) inhibitory activities of triterpenoids from roots of Glycine max (L.) Merr.

Cited 1 time in scopus
Metadata Downloads
Title
Human acyl-CoA: Cholesterol acyltransferase (hACAT) inhibitory activities of triterpenoids from roots of Glycine max (L.) Merr.
Author(s)
J H Lee; Young Bae Ryu; B W Lee; J H Kim; Woo Song Lee; Y D Park; Tae Sook Jeong; K H Park
Bibliographic Citation
Bulletin of Korean Chemical Society, vol. 29, no. 3, pp. 615-619
Publication Year
2008
Abstract
Eight triterpenoids, six lanostanes 1-6, one lupenane 7, and one oleanane 8, were isolated by bioactivity-guided fractionation of the ethylacetate extract from roots of Glycine max (L.) Merr. All isolated compounds were examined for their inhibitory activities against human ACAT-1 (hACAT-1) and human ACAT-2 (hACAT-2). Among them, three triterpenoids showed potent hACAT inhibitory activities, (24R)-ethylcholest-5-ene-3,7-diol (1) and 3β -hydroxylup-20(29)-en-28-oic acid (7) exhibited more potent inhibitory activity against hACAT-1 (1: IC50 = 25.0 ± 1.2 and 7: IC50 = 11.5 ± 0.4 μM) than hACAT-2 (1: IC50 = 102.0 ± 5.4 and 7: IC50 = 33.9 ± 3.7 αM), respectively. Interestingly, 5α ,8α -epidioxy-24(R)-methylcholesta-6,22-diene- 3β-ol (4) has proven to be a specific inhibitor against hACAT-1 (IC 50 = 38.7 ± 0.8 μM) compared to hACAT-2 (IC50 > 200). In conclusion, this is the first study to demonstrate that triterpenoids of G. max have potent inhibitory activities against hACAT-1 and hACAT-2.
Keyword
AtherosclerosisGlycine maxHuman acyl-coA: cholesterol acytransferase (hACAT)RootTriterpenoid
ISSN
0253-2964
Publisher
Wiley
DOI
http://dx.doi.org/10.5012/bkcs.2008.29.3.615
Type
Article
Appears in Collections:
Jeonbuk Branch Institute > Functional Biomaterial Research Center > 1. Journal Articles
Division of Biomaterials Research > Industrial Bio-materials Research Center > 1. Journal Articles
Files in This Item:
  • There are no files associated with this item.


Items in OpenAccess@KRIBB are protected by copyright, with all rights reserved, unless otherwise indicated.